Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Notice to Readers: Public Comment Sought on CDC's Vaccine Safety

In consultation with outside stakeholders, the CDC has undertaken a review of vaccine safety activities at CDC. As part of this effort, the CDC is seeking public comments regarding the current state of the agency's vaccine safety program and to identify ways in which excellence in vaccine safety monitoring, research and communication can be maximized and sustained in the future. Comments should focus on the objectives listed below:

1) Review the structure, function, credibility, effectiveness, efficiency and support of CDC's vaccine safety program and assess how it can be maximized and sustained.
• Assess the program's ability to detect emerging or rare adverse events.
• Assess the capacity of the program to provide comprehensive monitoring of the growing number of vaccines.
2) Review the intramural and extramural collaborative activities of the vaccine safety program and determine their effectiveness and efficiency.
• Assess additional steps CDC can institute to enhance coordination with other federal agencies and partners, including consumer and advocacy groups.
3) Determine the optimal organizational location for vaccine safety activities within the CDC to ensure scientific objectivity, transparency and oversight while at the same time ensuring that program priorities are appropriately established and are relevant to the immunization program and other stakeholder needs.

CDC will post presentations of facts about CDC's vaccine safety activities on the CDC Web site so that the public can make informed comments about the objectives listed above. The link to the objectives is at The links to the presentations are also provided on the Web site.

We invite the public to review the available information and follow the instructions for providing comments and input. The public comment period will end on October 12, 2004.

If you have any questions or need more information, please email the following address:

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version ( and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #